Drug Profile
DAR 201
Latest Information Update: 30 Jul 2015
Price :
$50
*
At a glance
- Originator DarPharma
- Class
- Mechanism of Action Dopamine D1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 08 Apr 2002 Preclinical trials in Parkinson's disease in USA (unspecified route)